|
|
Article: /C O R R E C T I O N -- AVANIR Pharmaceuticals/.
- Article from:
- PR Newswire
- Article date:
- December 26, 2002
CopyrightCOPYRIGHT 2002 PR Newswire Association LLC. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
-- In the news release, AVANIR Pharmaceuticals to Receive $24 Million for Rights to Abreva(R) North American Royalty Stream, issued earlier today by AVANIR Pharmaceuticals over PR Newswire, we are advised by the company that the receipt date of the "initial payment" referenced in the second paragraph, first sentence, should read "December 24, 2002" rather than "December 4, 2002" as originally issued inadvertently.
The complete, corrected text follows:
AVANIR Pharmaceuticals to Receive $24 Million for Rights to Abreva(R)
North American Royalty Stream
SAN DIEGO, Dec. 26 /PRNewswire-FirstCall/ -- AVANIR Pharmaceuticals announced ...